Literature DB >> 35927356

Targeting ASGR1 to lower cholesterol.

Daniel J Rader1,2,3,4,5.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35927356     DOI: 10.1038/s42255-022-00623-8

Source DB:  PubMed          Journal:  Nat Metab        ISSN: 2522-5812


× No keyword cloud information.
  2 in total

1.  Inclisiran: A First-in-Class siRNA Therapy for Lowering Low-Density Lipoprotein Cholesterol.

Authors:  Essie Samuel; Maya Watford; Ugochukwu O Egolum; David N Ombengi; Hua Ling; Drew W Cates
Journal:  Ann Pharmacother       Date:  2022-06-30       Impact factor: 3.154

2.  Post-translational control of beige fat biogenesis by PRDM16 stabilization.

Authors:  Qiang Wang; Huixia Li; Kazuki Tajima; Anthony R P Verkerke; Zachary H Taxin; Zhishuai Hou; Joanne B Cole; Fei Li; Jake Wong; Ichitaro Abe; Rachana N Pradhan; Tadashi Yamamuro; Takeshi Yoneshiro; Joel N Hirschhorn; Shingo Kajimura
Journal:  Nature       Date:  2022-08-17       Impact factor: 69.504

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.